Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats

Laboratory Investigation

Volumn 79, Issue 7, 1999, Pages 799-806

  Lindros, Kai O ^a   Jokelainen, Kalle ^b   Nanji, Amin A ^b,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE INHIBITOR; CYCLOOXYGENASE 2; DISULFIRAM; FISH OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; STEATOSIS;

ACETALDEHYDE; ALDEHYDE DEHYDROGENASE; ANIMALS; CYCLOOXYGENASE 2; ENZYME INHIBITORS; HEPATITIS, ALCOHOLIC; ISOENZYMES; MALE; NF-KAPPA B; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032808415     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Baeuerle PA and Baltimore D (1996). NF-κB: Ten years after. Cell 87:13-20.
2. Barnes PJ and Karin M (1997). Nuclear factor κB - A pivotal factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
3. Casini A, Cunningham M, Rojkind M, and Lieber CS (1991). Acetaldehyde increases procollagen type I and fibronectin gene transcription of cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 13: 758-765.
4. Chomczynski P and Sacchi N (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Dinchuk JE, Car BD, Focht RJ, Johnson JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, Czerniak PM, Gorry SA, and Trzaskos JS (1995). Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406-409.
6. Eriksson CJP and Sippel H (1977). The distribution and metabolism of acetaldehyde in rats during ethanol oxidation: The distribution of acetaldehyde in liver, brain, blood and breath. Biochem Pharmacol 26:241-249.
7. Eriksson CJ, Sippel HW, and Forsander OA (1977). The determination of acetaldehyde in biological samples by head-space chromatography. Anal Biochem 80:116-124.
8. French SW, Miyamoto K, and Tsukamoto H (1986). Ethanol-induced hepatic fibrosis in the rat: Role of the amount of dietary fat. Alcohol Clin Exp Res 10:135-195.
9. French SW, Wong K, Jui L, Albano E, Hagbjork AL, and Ingelman-Sundberg M (1993). Effect of ethanol on cytochrome P4502E1 (CYP2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 58:61-75.
10. Hellstrom-Lindahl E and Weiner H (1985). Effects of disulfiram on oxidation of benzaldehyde and acetaldehyde on rat liver. Biochem Pharmacol 34:1529-1534.
11. Herschman HR (1996). Prostaglandin synthase 2. Biochem Biophys Acta 1299:125-140.
12. Jokelainen K, Thomas P, Lindros K, and Nanji AA (1998). Acetaldehyde inhibits NF-κB activation through l κBαpreservation in rat Kupffer cells. Biochem Biophys Res Commun 253:834-836.
13. Koivula T and Koivisal M (1975). Different forms of rat liver aldehyde dehydrogenase and their subcellular distribution. Biochem Biophys Acta 397:9-23.
14. Koop DR (1986). Hydroxylation of P-nitrophenol by rabbit ethanol-inducible P450 isozyme 3a. Mol Pharmacol 29:399-404.
15. Lauterberg BH and Bilzer M (1998). Mechanisms of acetaldehyde hepatotoxicity. J Hepatol 7:384-390.
16. Li CJ, Nanji AA, Siakotos AN, and Lin RC (1997). Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease. Hepatology 26:650-657.
17. Lieber CS (1994). Alcohol and the liver, 1994 update. Gastroenterology 106:1085-1105.
18. Lin M, Rippe RA, Niemela O, Britteham G, and Tsukamoto H (1997). Role of iron in NF-κB activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol 272: G1355-G1364.
19. Lindros KO (1978). Acetaldehyde, its metabolism and role in the action of alcohol. In: Israel Y, Glaser FB, Kalant H, Popham RE, Schmidt W, Smart RG, editors. Research advances in alcohol and drug problems. New York: Plenum Press, 111-176.
20. Lindros KO, Koivula T, and Eriksson CJP (1975). Acetaldehyde levels during ethanol oxidation: A diet-induced change and its relation to liver aldehyde dehydrogenases and redox states. Life Sci 17:1589-1595.
21. Lindros KO, Vihma R, and Forsander OA (1972). Utilization and metabolic effects of acetaldehyde and ethanol in the perfused rat liver. Biochem J 126:945-951.
22. 4-induced hepatic injury is associated with inhibition of nuclear factor κ B binding. Hepatology 22:1474-1481.
23. Martini R, Ingelman-Sundberg M, and Murray M (1997). Pretranslational and posttranslational regulation of rat hepatic CYPs3A2 and 2E1 by disulfiram. Biochem Pharmacol 54:1323-1329.
24. May MJ and Ghosh S (1997). Rel/NF-κB and κB proteins: An overview. Semin Cancer Biol 8:63-73.
25. McClain CJ, Hill D, Schmidt J, and Diehl AM (1993). Cytokines and alcoholic liver disease. Semin Liver Dis 13:170-182.
26. Nanji AA and French SW (1989). Dietary linoleic acid is required for the development of experimentally induced alcoholic liver injury. Life Sci 44:223-227.
27. Nanji AA, Griniuviene B, Yacoub LK, Fogt F, and Tahan SR (1995). Intercellular adhesion molecule-1 expression in experimental alcoholic liver disease: Relationship to endotoxemia and TNFα messenger RNA. Exp Mol Pathol 62:42-51.
28. Nanji AA, Khwaja S, Tahan SR, and Sadrzadeh SMH (1994b). Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with liver injury in experimental alcoholic liver disease. J Pharmacol Exp Ther 269:1280-1285.
29. Nanji AA, Mendehall CL, and French SW (1989). Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 13:15-19.
30. Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR, and Dannenberg AJ (1997a). Enhanced cyclooxygenase-2 gene expression in alcohol liver disease in the rat. Gastroenterology 112:943-951.
31. Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F, Meydani M, and Dannenberg AJ (1995). Dietary saturated fatty acids: A novel treatment for alcoholic liver disease. Gastroenterology 109: 547-554.
32. Nanji AA and Zakim D (1996). Alcoholic liver disease. In: Zakim D, Boyer ID, editors. Hepatology: A textbook of liver disease, 3rd ed. Philadelphia: Saunders, 891-961.
33. Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaya S, Tahan SR, and Dannenberg AJ (1997b). Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26:1538-1545.
34. Nanji AA, Zhao S, Sadrzadeh SMH, and Waxman DJ (1994a). Use of reverse transcription polymerase chain reaction to evaluate in-vivo cytokine gene expression in rats fed ethanol for long periods of time. Hepatology 19:1483-1487.
35. Nobel CS, Kimland M, Nicholson DW, Orrenius S, and Slater AF (1997). Disulfiram is a potent inhibitor of proteases of the caspase family. Chem Res Toxicol 10:1319-1324.
36. Peters TJ and Ward RJ (1998). Role of acetaldehyde in the pathogenesis of alcoholic liver disease. Mol Aspects Med 10:179-190.
37. Pham TV, Nanji AA, Fong TL, Lin M, Yin W, Wang SC, Ohata M, and Tsukamoto H (1996). Iron and unsaturated fat as nutritional peroxidants: NFκB activation and induction of TNF-α and MIP-1 in experimental alcoholic liver disease (abstract). Hepatology 24:185A.
38. Ploemen JB, Vanlersel ML, Wormhoudt LW, Commandeur JN, Vermuelen NP, and VanBaderen PJ (1996). In vitro inhibition of rat and human glutathione-S-transferase isoenzymes by disulfiram and diethylthiocarbarnate. Biochem Pharmacol 52:197-204.
39. Stowell AR (1972). An improved method for the determination of acetaldehyde and ethanol in the perfused rat liver. Biochem J 126:945-951.
40. Thiele GM, Miller JA, Klassen LW, and Tuma DJ (1996). Long term ethanol administration alters the degradation of acetaldehyde adducts by liver endothelial cells. Hepatology 24: 643-648.
41. Tottmar O and Lindberg P (1977). Effects on rat liver acetaldehyde dehydrogenase in vitro and in vivo by coprine, the disulfiram-like constituent of Coprinus atramentarius. Acta Pharmacol Toxicol 40:476-481.
42. Tsukamoto H, Gaal K, and French SW (1990). Insight into the pathogenesis of alcoholic liver necrosis and fibrosis. Hepatology 12:599-608